Medic Vision Ltd., a company specializing in medical imaging solutions, announces it has received clearance from the U.S. Food and Drug Administration to market its SafeCT product in the USA. The SafeCT, recently unveiled at the 2010 RSNA meeting, processes and enhances images spanning a broad range of clinical applications acquired on a wide variety of CT scanners. SafeCT enables a dramatic 50% dose reduction in CT scans without compromising image quality and diagnostic information.
Recent health concerns over CT radiation in diagnostic imaging have given rise to dedicated dose reduction features in a limited number of new CT scanner models. Over 10,000 CT scanners are currently in use in the USA alone—with an estimated 30,000 worldwide—the majority of which are left without a suitable dose-reduction solution. SafeCT, which is compatible with most major CT platforms and PACS, can provide low-dose imaging functionality to these scanners, ensuring safe and efficacious CT scanning.
SafeCT has been clinically validated at leading medical centers, with hundreds of patients tested and results presented in a number of papers.
For more information, visit www.medicvision.com